FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1966541566> ?p ?o ?g. }

• W1966541566 endingPage "522" @default.
• W1966541566 startingPage "512" @default.
• W1966541566 abstract "Objective To review the efficacy and safety of inhaled corticosteroids (ICSs) when used to reduce daily oral corticosteroid (OCS) requirements in patients with severe persistent asthma and periodic requirements in patients with acute asthma exacerbations. Data Sources Clinical studies of the OCS-sparing effects of ICSs were located by searching MEDLINE databases from 1966 onward using the terms oral, steroid, and asthma in combination with the generic names for each marketed ICS. Study Selection Studies reporting on the use of ICSs to reduce OCS requirements in patients with persistent and acute asthma are included. Results Clinical study results consistently show that ICSs significantly improve asthma control and reduce OCS requirements among adults, children, and infants with persistent asthma. A dose reduction or complete discontinuation of use of OCSs is possible in most patients without loss of asthma control. ICSs also can control asthma during acute asthma exacerbations and reduce the need for short courses of OCSs. With many ICSs, the reductions in OCS use are accompanied by recovery of hypothalamic-pituitary-adrenal axis function, indicating that the safety of asthma therapy is improved when OCS requirements are decreased with ICSs. Of the available ICSs that may reduce OCS needs, budesonide appears to be the most intensively studied. Conclusions ICSs can reduce OCS requirements in adults and children with persistent asthma and during acute asthma exacerbations. The reduced systemic corticosteroid activity associated with ICS treatment improves the overall safety of asthma therapy. To review the efficacy and safety of inhaled corticosteroids (ICSs) when used to reduce daily oral corticosteroid (OCS) requirements in patients with severe persistent asthma and periodic requirements in patients with acute asthma exacerbations. Clinical studies of the OCS-sparing effects of ICSs were located by searching MEDLINE databases from 1966 onward using the terms oral, steroid, and asthma in combination with the generic names for each marketed ICS. Studies reporting on the use of ICSs to reduce OCS requirements in patients with persistent and acute asthma are included. Clinical study results consistently show that ICSs significantly improve asthma control and reduce OCS requirements among adults, children, and infants with persistent asthma. A dose reduction or complete discontinuation of use of OCSs is possible in most patients without loss of asthma control. ICSs also can control asthma during acute asthma exacerbations and reduce the need for short courses of OCSs. With many ICSs, the reductions in OCS use are accompanied by recovery of hypothalamic-pituitary-adrenal axis function, indicating that the safety of asthma therapy is improved when OCS requirements are decreased with ICSs. Of the available ICSs that may reduce OCS needs, budesonide appears to be the most intensively studied. ICSs can reduce OCS requirements in adults and children with persistent asthma and during acute asthma exacerbations. The reduced systemic corticosteroid activity associated with ICS treatment improves the overall safety of asthma therapy." @default.
• W1966541566 created "2016-06-24" @default.
• W1966541566 creator A5085218820 @default.
• W1966541566 creator A5090310464 @default.
• W1966541566 date "2004-05-01" @default.
• W1966541566 modified "2023-10-16" @default.
• W1966541566 title "Oral corticosteroid-sparing effects of inhaled corticosteroids in the treatment of persistent and acute asthma" @default.
• W1966541566 cites W1812633805 @default.
• W1966541566 cites W1873574768 @default.
• W1966541566 cites W1966584447 @default.
• W1966541566 cites W1968340866 @default.
• W1966541566 cites W1971065145 @default.
• W1966541566 cites W1971632633 @default.
• W1966541566 cites W1972039711 @default.
• W1966541566 cites W1975279103 @default.
• W1966541566 cites W1977589251 @default.
• W1966541566 cites W1979457017 @default.
• W1966541566 cites W1980428458 @default.
• W1966541566 cites W1987227460 @default.
• W1966541566 cites W1988315690 @default.
• W1966541566 cites W1990271017 @default.
• W1966541566 cites W1992036294 @default.
• W1966541566 cites W1996136296 @default.
• W1966541566 cites W2001860371 @default.
• W1966541566 cites W2003841397 @default.
• W1966541566 cites W2005626042 @default.
• W1966541566 cites W2010566912 @default.
• W1966541566 cites W2018874457 @default.
• W1966541566 cites W2020874051 @default.
• W1966541566 cites W2022044059 @default.
• W1966541566 cites W2030050314 @default.
• W1966541566 cites W2040948705 @default.
• W1966541566 cites W2045893079 @default.
• W1966541566 cites W2051146255 @default.
• W1966541566 cites W2051856800 @default.
• W1966541566 cites W2052140026 @default.
• W1966541566 cites W2056709743 @default.
• W1966541566 cites W2067039330 @default.
• W1966541566 cites W2082466693 @default.
• W1966541566 cites W2084336650 @default.
• W1966541566 cites W2085977034 @default.
• W1966541566 cites W2086754370 @default.
• W1966541566 cites W2093474523 @default.
• W1966541566 cites W2094269361 @default.
• W1966541566 cites W2097200052 @default.
• W1966541566 cites W2102417550 @default.
• W1966541566 cites W2103504215 @default.
• W1966541566 cites W2107315363 @default.
• W1966541566 cites W2111482500 @default.
• W1966541566 cites W2113370598 @default.
• W1966541566 cites W2129327022 @default.
• W1966541566 cites W2137607488 @default.
• W1966541566 cites W2138040883 @default.
• W1966541566 cites W2138693512 @default.
• W1966541566 cites W2139054312 @default.
• W1966541566 cites W2139970161 @default.
• W1966541566 cites W2143938468 @default.
• W1966541566 cites W2148782900 @default.
• W1966541566 cites W2149452009 @default.
• W1966541566 cites W2155345300 @default.
• W1966541566 cites W2155655610 @default.
• W1966541566 cites W2169160058 @default.
• W1966541566 cites W2169940583 @default.
• W1966541566 cites W2169979000 @default.
• W1966541566 cites W2170325045 @default.
• W1966541566 cites W2412422422 @default.
• W1966541566 cites W2415585040 @default.
• W1966541566 cites W2594805288 @default.
• W1966541566 cites W4249876228 @default.
• W1966541566 cites W4367329939 @default.
• W1966541566 cites W3148963309 @default.
• W1966541566 doi "https://doi.org/10.1016/s1081-1206(10)61758-9" @default.
• W1966541566 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15191019" @default.
• W1966541566 hasPublicationYear "2004" @default.
• W1966541566 type Work @default.
• W1966541566 sameAs 1966541566 @default.
• W1966541566 citedByCount "23" @default.
• W1966541566 countsByYear W19665415662014 @default.
• W1966541566 countsByYear W19665415662015 @default.
• W1966541566 countsByYear W19665415662018 @default.
• W1966541566 countsByYear W19665415662019 @default.
• W1966541566 countsByYear W19665415662021 @default.
• W1966541566 countsByYear W19665415662022 @default.
• W1966541566 crossrefType "journal-article" @default.
• W1966541566 hasAuthorship W1966541566A5085218820 @default.
• W1966541566 hasAuthorship W1966541566A5090310464 @default.
• W1966541566 hasConcept C126322002 @default.
• W1966541566 hasConcept C177713679 @default.
• W1966541566 hasConcept C187212893 @default.
• W1966541566 hasConcept C2776042228 @default.
• W1966541566 hasConcept C2776136866 @default.
• W1966541566 hasConcept C2776804153 @default.
• W1966541566 hasConcept C2778715236 @default.
• W1966541566 hasConcept C42219234 @default.
• W1966541566 hasConcept C71924100 @default.
• W1966541566 hasConceptScore W1966541566C126322002 @default.
• W1966541566 hasConceptScore W1966541566C177713679 @default.
• W1966541566 hasConceptScore W1966541566C187212893 @default.

• next